생물 안전 작업대 시장 : 시장 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of biological safety cabinet (BSC) Market

The global biological safety cabinet (BSC) market was valued at USD 330.08 million in 2025 and is projected to grow from USD 343.09 million in 2026 to USD 496.26 million by 2034, registering a CAGR of 4.70% during 2026-2034. North America dominated the market in 2025, accounting for a 38.46% share, driven by strong laboratory infrastructure and increasing research activities.

Biological safety cabinets are enclosed, ventilated laboratory workspaces designed to protect laboratory personnel, the environment, and samples from biohazards and infectious agents. Their importance has grown significantly due to the rising burden of chronic and infectious diseases, expanding pharmaceutical R&D, and heightened awareness regarding laboratory safety standards.

Market Drivers

Rising Prevalence of Chronic and Infectious Diseases

The growing number of infectious diseases globally is a key growth driver. According to 2025 WHO data, approximately 3.0-5.0 million severe seasonal influenza cases occur annually worldwide. Additionally, CDC statistics reported 9,633 tuberculosis cases in 2023 in the U.S., compared to 8,332 in 2022, reflecting rising diagnostic needs.

Increasing patient admissions and diagnostic testing volumes have strengthened demand for biosafety cabinets across hospitals and laboratories. Furthermore, pharmaceutical and biotechnology companies are expanding R&D pipelines, further boosting adoption.

Growing Research & Development Activities

With around 5,000 pharmaceutical companies operating in the U.S. in 2025, the need for controlled and contamination-free laboratory environments continues to rise. Government funding and biosecurity preparedness initiatives are also accelerating product penetration.

Market Restraints

High Cost of Devices

One of the primary limiting factors is the high cost of biosafety cabinets. According to 2024 industry data, prices range between USD 6,000 and USD 15,000 depending on configuration. Advanced HEPA filtration, UV systems, regulatory compliance requirements (NSF/ANSI 49 in the U.S., EN 12469 in Europe), and energy consumption significantly increase ownership costs.

Regulatory and Operational Challenges

Stringent compliance requirements, frequent audits, certification updates, and supply chain constraints for components such as filters and UV lamps create barriers, particularly for smaller manufacturers and emerging markets.

Market Opportunities

Emerging nations such as Brazil, Mexico, China, and India present significant growth potential due to expanding healthcare infrastructure and increasing R&D investments. Government initiatives to strengthen pathogen research laboratories and biosafety preparedness are creating new demand avenues.

For instance, Brazil initiated construction of a Biosafety Level 4 (BSL-4) laboratory in July 2024, reflecting growing regional focus on infectious disease research.

Market Trends

Technological Advancements

The integration of advanced sensors, AI-enabled predictive maintenance, automated compliance monitoring, and improved containment features is transforming traditional biosafety cabinets. Modular designs and enhanced user interfaces are gaining popularity.

In May 2025, Thermo Fisher Scientific launched the 1500 Series Class II Type A2 BSC, strengthening its product portfolio. Similarly, in August 2024, Labconco introduced a redesigned Logic Biosafety Cabinet.

Segmentation Analysis

By Type

The market is segmented into Class I, Class II, and Class III cabinets. The Class II segment dominated in 2026 with an 88.95% market share, owing to its comprehensive protection capabilities for personnel, products, and the environment.

Class I cabinets are projected to grow steadily due to rising lab safety initiatives.

By End User

The biotechnology and pharmaceutical companies segment held a 39.72% share in 2026, driven by expanding R&D activities and increasing drug development initiatives. Hospitals & clinical laboratories and academic research institutes also contribute significantly to demand.

Regional Insights

North America

North America led the market with a value of USD 126.96 million in 2025, increasing to USD 132.43 million in 2026. Strong healthcare spending (U.S. per capita healthcare expenditure of USD 14,570 in 2023) and advanced laboratory infrastructure support regional dominance. The U.S. market alone is projected to reach USD 117.86 million in 2026.

Europe

Europe is expected to grow steadily, supported by regulatory certifications and expanding research labs. The UK market is projected at USD 24.75 million in 2026, while Germany is expected to reach USD 28.58 million in 2026.

Asia Pacific

Asia Pacific is anticipated to register considerable growth. By 2026, China is projected to reach USD 19.42 million, Japan USD 11.69 million, and India USD 6.97 million, driven by expanding healthcare investments and awareness initiatives.

Latin America & Middle East & Africa

These regions are witnessing growing healthcare infrastructure investments and biosafety initiatives, supporting steady market expansion.

Competitive Landscape

Key players include Thermo Fisher Scientific Inc., Haier Biomedical, Esco Micro Pte. Ltd., Labconco, Kewaunee International Group, Baker Co., Germfree, and Biobase Biodusty. Companies are focusing on acquisitions, certifications, and innovative launches to expand global presence.

For example:

• January 2025 - Biobase launched a radiation protection biosafety cabinet.
• November 2024 - Kewaunee acquired NuAire to diversify its BSC portfolio.

Conclusion

The global biological safety cabinet market demonstrates stable growth, increasing from USD 330.08 million in 2025 to USD 343.09 million in 2026, and projected to reach USD 496.26 million by 2034, growing at a 4.70% CAGR. Rising infectious disease prevalence, expanding pharmaceutical R&D, and technological advancements are key growth drivers. Although high costs and regulatory complexities present challenges, strong government funding, emerging market expansion, and innovation in AI-integrated biosafety systems are expected to sustain long-term market growth through 2034.

Segmentation By Type

• Class I
• Class II
  • Type A
  • Type B
  • Type C
  • Class III

By End User

• Hospitals & Clinical Laboratories
• Academic & Research Institutes
• Biotechnology and Pharmaceutical Companies
• Others

By Geography

• North America (By Type, By End User, and by Country)
  • U.S. (By Type)
  • Canada (By Type)
• Europe (By Type, By End User, and by Country/Sub-region)
  • U.K. (By Type)
  • Germany (By Type)
  • France (By Type)
  • Italy (By Type)
  • Spain (By Type)
  • Scandinavia (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Type, By End User, and by Country/Sub-region)
  • China (By Type)
  • Japan (By Type)
  • India (By Type)
  • Australia (By Type)
  • Southeast Asia (By Type)
  • Rest of Asia Pacific (By Type)
• Latin America (By Type, By End User, and by Country/Sub-region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Type, By End User, and by Country/Sub-region)
  • GCC (By Type)
  • South Africa (By Type)
  • Rest of the Middle East & Africa (By Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Diseases, Key Countries/Regions, 2025/2025
• 4.2. Technological Advancements in Biological Safety Cabinets
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Biological Safety Cabinet Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Class I
  • 5.1.2. Class II
    • 5.1.2.1. Type A
    • 5.1.2.2. Type B
    • 5.1.2.3. Type C
  • 5.1.3. Class III
• 5.2. Market Analysis, Insights and Forecast - By End User
  • 5.2.1. Hospitals & Clinical Laboratories
  • 5.2.2. Academic & Research Institutes
  • 5.2.3. Biotechnology and Pharmaceutical Companies
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Biological Safety Cabinet Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Class I
  • 6.1.2. Class II
    • 6.1.2.1. Type A
    • 6.1.2.2. Type B
    • 6.1.2.3. Type C
  • 6.1.3. Class III
• 6.2. Market Analysis, Insights and Forecast - By End User
  • 6.2.1. Hospitals & Clinical Laboratories
  • 6.2.2. Academic & Research Institutes
  • 6.2.3. Biotechnology and Pharmaceutical Companies
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
    • 6.3.1.1. By Type
  • 6.3.2. Canada
    • 6.3.2.1. By Type

7. Europe Biological Safety Cabinet Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Class I
  • 7.1.2. Class II
    • 7.1.2.1. Type A
    • 7.1.2.2. Type B
    • 7.1.2.3. Type C
  • 7.1.3. Class III
• 7.2. Market Analysis, Insights and Forecast - By End User
  • 7.2.1. Hospitals & Clinical Laboratories
  • 7.2.2. Academic & Research Institutes
  • 7.2.3. Biotechnology and Pharmaceutical Companies
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.3.1. U.K.
    • 7.3.1.1. By Type
  • 7.3.2. Germany
    • 7.3.2.1. By Type
  • 7.3.3. France
    • 7.3.3.1. By Type
  • 7.3.4. Spain
    • 7.3.4.1. By Type
  • 7.3.5. Italy
    • 7.3.5.1. By Type
  • 7.3.6. Scandinavia
    • 7.3.6.1. By Type
  • 7.3.7. Rest of Europe
    • 7.3.7.1. By Type

8. Asia Pacific Biological Safety Cabinet Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Class I
  • 8.1.2. Class II
    • 8.1.2.1. Type A
    • 8.1.2.2. Type B
    • 8.1.2.3. Type C
  • 8.1.3. Class III
• 8.2. Market Analysis, Insights and Forecast - By End User
  • 8.2.1. Hospitals & Clinical Laboratories
  • 8.2.2. Academic & Research Institutes
  • 8.2.3. Biotechnology and Pharmaceutical Companies
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.3.1. Japan
    • 8.3.1.1. By Type
  • 8.3.2. Australia
    • 8.3.2.1. By Type
  • 8.3.3. China
    • 8.3.3.1. By Type
  • 8.3.4. India
    • 8.3.4.1. By Type
  • 8.3.5. Southeast Asia
    • 8.3.5.1. By Type
  • 8.3.6. Rest of Asia Pacific
    • 8.3.6.1. By Type

9. Latin America Biological Safety Cabinet Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Class I
  • 9.1.2. Class II
    • 9.1.2.1. Type A
    • 9.1.2.2. Type B
    • 9.1.2.3. Type C
  • 9.1.3. Class III
• 9.2. Market Analysis, Insights and Forecast - By End User
  • 9.2.1. Hospitals & Clinical Laboratories
  • 9.2.2. Academic & Research Institutes
  • 9.2.3. Biotechnology and Pharmaceutical Companies
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.3.1. Brazil
    • 9.3.1.1. By Type
  • 9.3.2. Mexico
    • 9.3.2.1. By Type
  • 9.3.3. Rest of Latin America
    • 9.3.3.1. By Type

10. Middle East & Africa Biological Safety Cabinet Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Class I
  • 10.1.2. Class II
    • 10.1.2.1. Type A
    • 10.1.2.2. Type B
    • 10.1.2.3. Type C
  • 10.1.3. Class III
• 10.2. Market Analysis, Insights and Forecast - By End User
  • 10.2.1. Hospitals & Clinical Laboratories
  • 10.2.2. Academic & Research Institutes
  • 10.2.3. Biotechnology and Pharmaceutical Companies
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.3.1. GCC
    • 10.3.1.1. By Type
  • 10.3.2. South Africa
    • 10.3.2.1. By Type
  • 10.3.3. Rest of Middle East & Africa
    • 10.3.3.1. By Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  • 11.2.1. Thermo Fisher Scientific Inc.
  • 11.2.2. Haier Biomedical
  • 11.2.3. Esco Micro Pte. Ltd.
  • 11.2.4. Labconco
  • 11.2.5. Kewaunee International Group
  • 11.2.6. Brinda Pharma Technologies
  • 11.2.7. Biobase Biodusty(Shandong), Co., Ltd.
  • 11.2.8. Baker Co.
  • 11.2.9. Germfree